Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (661-670 of 743) with videos related to

Pageof 75
Sort By:
Cancer Research|March 26, 2009
A novel prostate cancer susceptibility locus at 19q13Fang-Chi Hsu, Jielin Sun, Fredrik Wiklund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Inherited genetic variant predisposes to aggressive but not indolent prostate cancerJianfeng Xu, Siqun Lilly Zheng, Sarah D Isaacs, et al.
BMJ Open|October 22, 2025
Emergency department-initiated palliative care screening among older adults: a systematic review and meta-analysis protocolDimitri E Lin, Satheesh Gunaga, Fabrice I Mowbray, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
Rheumatology (Oxford, England)|March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation studyA W Morgan, V H Keyte, S J Babbage, et al.
Nature Communications|September 22, 2020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritisFrank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
Brain : a Journal of Neurology|August 16, 2021
Reply: Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trialsRoy T Steigbigel, David A Cooper, Hedy Teppler, et al.
Pageof 75

Showing results (661-670 of 743) with videos related to

Sort By:
Pageof 75
Cancer Research|March 26, 2009
A novel prostate cancer susceptibility locus at 19q13Fang-Chi Hsu, Jielin Sun, Fredrik Wiklund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Inherited genetic variant predisposes to aggressive but not indolent prostate cancerJianfeng Xu, Siqun Lilly Zheng, Sarah D Isaacs, et al.
BMJ Open|October 22, 2025
Emergency department-initiated palliative care screening among older adults: a systematic review and meta-analysis protocolDimitri E Lin, Satheesh Gunaga, Fabrice I Mowbray, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
Rheumatology (Oxford, England)|March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation studyA W Morgan, V H Keyte, S J Babbage, et al.
Nature Communications|September 22, 2020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritisFrank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
Brain : a Journal of Neurology|August 16, 2021
Reply: Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trialsRoy T Steigbigel, David A Cooper, Hedy Teppler, et al.
Pageof 75